US7427181091
US7427181091
Procter & Gamble Company (The)
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 351.52B EUR | 340.77B EUR | 336.34B EUR | 333.05B EUR |
Enterprise Value | 376.11B EUR | 365.85B EUR | 361.06B EUR | 358.87B EUR |
Valuation Multiples | ||||
Trailing P/E | 22.84x | 21.24x | 20.24x | 26.26x |
Forward P/E | 20.45x | -- | -- | -- |
Price to Sales | 4.04x | 3.92x | 3.88x | 5.09x |
Price to Book | 6.59x | 6.3x | 6.17x | 6.28x |
EV/Revenue | 4.32x | 4.2x | 4.16x | 5.48x |
EV/EBITDA | 15.2x | 14.99x | 14.51x | 19x |
Price to FCF (P/FCF) | 26.47x | 22.5x | 22.38x | 27.75x |
EV/FCF | 28.32x | 24.15x | 24.03x | 29.9x |
FCF Yield | 3.78% | 4.44% | 4.47% | 3.6% |